Spironolactone Tablet
Product Images NDC 68071-3795

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-3795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3795 9)

Pdp (68071 3795 9)
Packaging label for Spironolactone 50 mg tablets, supplied in a bottle of 90 tablets by NuCare Pharmaceuticals, Inc. The label includes product identifiers like NDC 68071-3795, manufacturing details, and tablet description stating round, flat beveled white to almost white tablets with specific debossed markings. It includes warnings to keep out of reach of children and storage temperature instructions.*
FDA Label Image

Figure (Spironolactone Fig1)

Figure (Spironolactone Fig1)
A Kaplan-Meier survival curve comparing the probability over 42 months for two groups: one treated with spironolactone and one given a placebo. The y-axis represents probability, and the x-axis represents time in months. The spironolactone group has a higher survival probability than the placebo group, with a log-rank p-value less than 0.001 indicating statistical significance.*
FDA Label Image

Fig2 (Spironolactone Fig2)

Fig2 (Spironolactone Fig2)
A forest plot chart depicting hazard ratios (HR) and 95% confidence intervals (CI) across various subgroups including age, sex, race, LVEF (%), heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, and medication use (Digoxin, ACEI, Beta Blocker). The chart compares outcomes for spironolactone versus placebo, showing subgroup sizes and variability in treatment effect.*
FDA Label Image

Str1 (Spironolactone Str1)

Str1 (Spironolactone Str1)
Chemical structure diagram of spironolactone, depicting its molecular framework with rings and functional groups shown clearly.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.